Physician profile
Ari Hadar
NPI 1578141495
$1,724.30
in general payments reported to CMS, 2019-2025
11 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $441 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $568.12 | 2024-2025 | Accolade Sr, Watchman, General - Therapies |
| Medtronic, INC. | $355.58 | 2025 | Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $272.67 | 2025 | Aveir, Assurity |
| Shockwave Medical, INC | $133.91 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.72 | 2024-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $99.19 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $48.91 | 2024 | |
| Amgen INC. | $43.70 | 2024-2025 | Repatha, Repatha |
| Abiomed | $43.16 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $35.38 | 2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $18.96 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Hadar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.